Abstract
Aim:
To investigate specific changes in metabolites and proteins of Kidney-Yin Deficiency Syndrome (KYDS) patients with diabetes mellitus (DM) in China.
Methods:
KYDS (n=29) and non-KYDS (n=23) patients with DM were recruited for this study. The KYDS was diagnosed by two senior TCM clinicians separately. The metabonomic and proteomic profiles of the patients were assessed using a metabonomic strategy based on NMR with multivariate analysis and a proteomic strategy based on MALDI-TOF-MS, respectively.
Results:
Eighteen upregulated peptides and thirty downregulated peptides were observed in the plasma of the KYDS patients. Comparing the proteomic profiles of the KYDS and non-KYDS groups, however, no significantly differentially expressed peptides were found. At the same time, major metabolic alterations were found to distinguish the two groups, including eight significantly changed metabolites (creatinine, citrate, TMAO, phenylalanine, tyrosine, alanine, glycine and taurine). The levels of creatinine, citrate, TMAO, phenylalanine and tyrosine were decreased, whereas the levels of alanine, glycine and taurine were increased in the KYDS patients. These biochemical changes were found to be associated with alterations in amino acid metabolism, energy metabolism and gut microflora.
Conclusion:
The identification of distinct expression profiles of metabolites and signaling pathways in KYDS patients with DM suggests that there are indeed molecular signatures underlying the principles of 'Syndrome Differentiation' in traditional Chinese medicine.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Ma T, Tan CG, Zhang H, Wang MQ, Ding WJ, Li S . Bridging the gap between traditional Chinese medicine and systems biology: the connection of Cold Syndrome and NEI network. Mol Biosystems 2010; 6: 613–9.
Dai JY, Sun SJ, Cao HJ, Zheng NN, Wang WY, Gou XJ, et al. Applications of new technologies and new methods in ZHENG differentiation. Evid Based Complement Alternat Med 2012; 2012: 298014.
Jiang M, Zhang C, Zheng G, Guo HT, Li L, Yang J, et al. Traditional Chinese medicine Zheng in the Era of evidence-based medicine: a literature analysis. Evid Based Complement Alternat Med 2012; 2012: 409568.
Oberg AL, Kennedy RB, Li P, Ovsyannikova IG, Poland GA . Systems biology approaches to new vaccine development. Curr Opin Immunol 2011; 23: 436–43.
Nicholson JK, Connelly J, Lindon JC, Holmes E . Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002; 1: 153–61.
Zhang A, Sun H, Wang Z, Sun W, Wang P, Wang X . Metabolomics: towards understanding traditional Chinese medicine. Planta Med 2010; 76: 2026–35.
Bakal C, Linding R, Llense F, Heffern E, Martin-Blanco E, Pawson T, et al. Phosphorylation networks regulating JNK activity in diverse genetic backgrounds. Science 2008; 322: 453–6.
Desiderio C, Rossetti DV, Iavarone F, Messana I, Castagnola M . Capillary electrophoresis — mass spectrometry: recent trends in clinical proteomics. J Pharm Biomed Anal 2010; 53: 1161–9.
Dai W, Wei C, Kong H, Jia Z, Han J, Zhang F, et al. Effect of the traditional Chinese medicine tongxinluo on endothelial dysfunction rats studied by using urinary metabonomics based on liquid chromatography-mass spectrometry. J Pharm Biomed Anal 2011; 56: 86–92.
Yu BB, Zhou CX, Zhang JY, Ling Y, Hu QF, Wang Y, et al. Latest study on the relationship between pathological process of inflammatory injury and the syndrome of spleen deficiency and fluid retention in Alzheimer's disease. Evid Based Complement Alternat Med 2014; 2014: 743541.
Sun S, Dai J, Wang W, Cao H, Fang J, Hu YY, et al. Metabonomic evaluation of ZHENG differentiation and treatment by Fuzhenghuayu Tablet in hepatitis-B-caused cirrhosis. Evid Based Complement Alternat Med 2012; 2012: 453503.
Wang Q, Yao S . Molecular basis for cold-intolerant yang-deficient constitution of traditional Chinese medicine. Am J Chin Med 2008; 36: 827–34.
Wang X, Zhang A, Han Y, Wang P, Sun H, Song G, et al. Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol Cell Proteomics 2012; 11: 370–80.
Wold S, Antti H, Lindgren F, Ohman J . Orthogonal signal correction of near-infrared spectra. Chemometr Intell Lab Syst 1998; 44: 175–85.
Lindon JC, Nicholson JK, Everett JR . NMR spectroscopy of biofluid. Annual Reports on NMR Spectroscopy 1999; 38: 1–88.
Jiang M, Lu C, Zhang C, Yang J, Tan Y, Lu A, et al. Syndrome differentiation in modern research of traditional Chinese medicine. J Ethnopharmacol 2012; 140: 634–42.
Ransohoff DF . Opinion - Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 2005; 5: 142–9.
Hu J, Coombes KR, Morris JS, Baggerly KA . The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales. Brief Funct Genomic Proteomic 2005; 3: 322–31.
McLerran D, Grizzle WE, Feng Z, Bigbee WL, Banez LL, Cazares LH, et al. Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias. Clin Chem 2008; 54: 44–52.
McLerran D, Grizzle WE, Feng Z, Thompson IM, Bigbee WL, Cazares LH, et al. SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. Clin Chem 2008; 54: 53–60.
Yue QX, Cao ZW, Guan SH, Liu XH, Tao L, Wu WY, et al. Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network. Mol Cell Proteomics 2008; 7: 949–61.
Zhou YW, Xu PC, Cheng Y . Basic pathogenesis of asthenia of healthy energy and blood stasis in liver cirrhosis studied by serum proteomics. Zhongguo Zhong Xi Yi Jie He Za Zhi 2011; 31: 595–602.
Van Eyk JE . Overview: the maturing of proteomics in cardiovascular research. Circ Res 2011; 108: 490–8.
Wang X, Sun H, Zhang A, Sun W, Wang P, Wang Z . Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine. J Pharm Biomed Anal 2011; 55: 859–68.
Jian WX, Yuan ZK, Huang XP . Detection and analysis on plasma metabolomics in patient with coronary heart disease of Xin-blood stasis syndrome pattern. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010; 30: 579–84.
Jiang HQ, Li YL, Xie J . Urine metabonomic study on hypertension patients of ascendant hyperactivity of gan yang syndrome by high performance liquid chromatography coupled with time of flight mass spectrometry. Zhongguo Zhong Xi Yi Jie He Za Zhi 2012; 32: 333–7.
Kerai MD, Waterfield CJ, Kenyon SH, Asker DS, Timbrell JA . Reversal of ethanol-induced hepatic steatosis and lipid peroxidation by taurine: a study in rats. Alcohol Alcohol 1999; 34: 529–41.
Chiarla C, Giovannini I, Siegel JH, Boldrini G, Castagneto M . The relationship between plasma taurine and other amino acid levels in human sepsis. J Nutr 2000; 130: 2222–7.
Huang DX, Yang J, Lu XM, Deng Y, Xiong ZL, Li FM . An integrated plasma and urinary metabonomic study using UHPLC-MS: intervention effects of Epimedium koreanum on 'Kidney-Yang Deficiency syndrome' rats. J Pharm Biomed Anal 2013; 76: 200–6.
Lu XM, Xiong ZL, Li JJ, Zheng SN, Huo TG, Li FM . Metabonomic study on 'Kidney-Yang Deficiency syndrome' and intervention effects of Rhizoma Drynariae extracts in rats using ultra performance liquid chromatography coupled with mass spectrometry. Talanta 2011; 83: 700–8.
Chen MJ, Zhao LP, Jia W . Metabonomic study on the biochemical profiles of a hydrocortisone-induced animal model. J Proteome Res 2005; 4: 2391–6.
Holmes E, Nicholson JK, Nicholls AW, Lindon JC, Connor SC, Polley S, et al. The identification of novel biomarkers of renal toxicity using automatic data reduction techniques and PCA of proton NMR spectra of urine. Chemometr Intell Lab Syst 1998; 44: 245–55.
Akira K, Masu S, Imachi M, Mitome H, Hashimoto M, Hashimoto T . 1H NMR-based metabonomic analysis of urine from young spontaneously hypertensive rats. J Pharm Biomed Anal 2008; 46: 550–6.
Acknowledgements
This study was supported by grants from Chinese Scientific and Technological Major Special Project (Grant No 2014ZX09J14103-03A), the Key Program of Natural Science Foundation of China (Grant No 90709012) and the National Natural Science Foundation of China (Grant No 30701073).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Jiang, N., Liu, Hf., Li, Sd. et al. An integrated metabonomic and proteomic study on Kidney-Yin Deficiency Syndrome patients with diabetes mellitus in China. Acta Pharmacol Sin 36, 689–698 (2015). https://doi.org/10.1038/aps.2014.169
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2014.169
Keywords
This article is cited by
-
Yin/Yang associated differential responses to Psoralea corylifolia Linn. In rat models: an integrated metabolomics and transcriptomics study
Chinese Medicine (2023)
-
From Xiaoke to diabetes mellitus: a review of the research progress in traditional Chinese medicine for diabetes mellitus treatment
Chinese Medicine (2023)
-
Taurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathway
Cell Death & Disease (2018)
-
Taurine protects against As2O3-induced autophagy in livers of rat offsprings through PPARγ pathway
Scientific Reports (2016)
-
Fangjiomics: revealing adaptive omics pharmacological mechanisms of the myriad combination therapies to achieve personalized medicine
Acta Pharmacologica Sinica (2015)
